Case number 2021-1495
Tris Pharma, Inc. v. Actavis Laboratories FL, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 15, 2022 | 51 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [866488] [MVH] [Entered: 08/15/2022 09:29 AM] (1) |
| Jul 10, 2022 | 0 | TRIS PHARMA, INC. v. ACTAVIS LABORATORIES FL, INC. [OPINION] [nonprecedential] (0) |
| Jul 7, 2022 | 50 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [859506] [MVH] [Entered: 07/07/2022 09:09 AM] (1) |
| Jul 7, 2022 | 49 | OPINION filed for the court by Moore, Chief Judge; Chen, Circuit Judge and Hughes, Circuit Judge. Nonprecedential Opinion. Service as of this date by the Clerk of Court. [859504] [MVH] [Entered: 07/07/2022 09:08 AM] (13) |
| Mar 8, 2022 | 48 | Submitted after ORAL ARGUMENT to Panel: Moore, Chief Judge; Chen, Circuit Judge and Hughes, Circuit Judge.Arguing counsel: Brian Timothy Burgess for Actavis Laboratories FL, Inc. and Errol Taylor for Tris Pharma, Inc..Oral Argument Audio available here. [835450] [MJL] [Entered: 03/08/2022 03:02 PM] (0) |
| Mar 3, 2022 | 47 | Letter from Appellee Tris Pharma, Inc. regarding Revised Protocols for In-Person Argument. Service: 03/03/2022 by email. [834604] [21-1495] [Errol Taylor] [Entered: 03/03/2022 11:49 AM] (1) |
| Mar 3, 2022 | 46 | Letter from Appellant Actavis Laboratories FL, Inc. regarding Argument Protocols. Service: 03/03/2022 by email. [834597] [21-1495] [Brian Burgess] [Entered: 03/03/2022 11:44 AM] (1) |
| Mar 2, 2022 | 45 | IMPORTANT NOTE to counsel scheduled to argue in-person at the Federal Circuit in March 2022: Arguing counsel and any accompanying individual will be required to (1) show proof of vaccination, (2) show proof of a negative PCR COVID-19 test taken within the past 72 hours, and (3) wear an approved mask. See Revised Protocols for In-Person Argument. No later than 12:00 p.m. (Eastern) on Friday, March 4, 2022, in-person arguing counsel must file either a letter acknowledging these requirements or an amended Certification of Compliance with Revised Protocols for In-Person Argument electing to appear remotely instead. Failure to timely file or failure to adhere to these protocols when entering the building may result in the inability to appear in person. [834350] [JCP] [Entered: 03/02/2022 01:22 PM] (0) |
| Feb 1, 2022 | 44 | Amended Response to notice of oral argument from Appellee Tris Pharma, Inc.. Service: 02/01/2022 by email. [828458] [21-1495] [Errol Taylor] [Entered: 02/01/2022 06:21 PM] (4) |
| Feb 1, 2022 | 43 | Response to notice of oral argument from Appellant Actavis Laboratories FL, Inc.. Service: 02/01/2022 by email. [828434] [21-1495] [Brian Burgess] [Entered: 02/01/2022 04:31 PM] (3) |
| Jan 31, 2022 | 42 | Response to notice of oral argument from Appellee Tris Pharma, Inc.. Service: 01/31/2022 by email. [828105] [21-1495] [Errol Taylor] [Entered: 01/31/2022 04:50 PM] (2) |
| Jan 21, 2022 | 41 | NOTICE OF ORAL ARGUMENT. Panel: 2203C. Case scheduled March 8, 2022. Response to Notice of Oral Argument due: 02/04/2022. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [826056] [JCP] [Entered: 01/21/2022 02:45 PM] (2) |
| Nov 12, 2021 | 40 | The following conflict dates submitted by Errol Taylor for Tris Pharma, Inc. have been accepted by the court: 01/10/2022, 01/11/2022, 01/12/2022, 01/13/2022, 01/14/2022. [811826] [MJL] [Entered: 11/12/2021 11:02 AM] (0) |
| Nov 12, 2021 | 39 | Notice from Appellee Tris Pharma, Inc. regarding conflicts with oral argument. Service: 11/12/2021 by email. [811763] [21-1495] [Errol Taylor] [Entered: 11/12/2021 08:53 AM] (3) |
| Sep 9, 2021 | 38 | The following conflict date submitted by Errol Taylor for Tris Pharma, Inc. has been accepted by the court: 11/01/2021. [798017] [MJL] [Entered: 09/09/2021 11:23 AM] (0) |
| Sep 9, 2021 | 37 | The following conflict dates submitted by Brian Timothy Burgess for Actavis Laboratories FL, Inc. have been accepted by the court: 02/07/2022, 02/08/2022, 02/09/2022, 02/10/2022, 02/11/2022. [798015] [MJL] [Entered: 09/09/2021 11:21 AM] (0) |
| Aug 31, 2021 | 34 | Notice from Appellee Tris Pharma, Inc. regarding conflicts with oral argument. Service: 08/31/2021 by email. [796355] [21-1495] [Errol Taylor] [Entered: 08/31/2021 03:08 PM] (3) |
| Aug 27, 2021 | 36 | 6 paper copies of Doc. No. [19] received from Appellee Tris Pharma, Inc.. [796625] [VDW] [Entered: 09/01/2021 02:08 PM] (0) |
| Aug 27, 2021 | 33 | Notice from Appellant Actavis Laboratories FL, Inc. regarding conflicts with oral argument. Service: 08/27/2021 by email. [795828] [21-1495] [Brian Burgess] [Entered: 08/27/2021 05:01 PM] (4) |
| Aug 26, 2021 | 35 | 6 paper copies of Doc. No. [29] received from Appellant Actavis Laboratories FL, Inc.. [796550] [VDW] [Entered: 09/01/2021 10:37 AM] (0) |
| Aug 26, 2021 | 32 | 6 paper copies of Doc. No. [15], [20] received from Appellant Actavis Laboratories FL, Inc. [795827] [EKD] [Entered: 08/27/2021 04:59 PM] (0) |
| Aug 25, 2021 | 31 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [795219] [EKD] [Entered: 08/25/2021 03:08 PM] (1) |
| Aug 25, 2021 | 30 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [795218] [EKD] [Entered: 08/25/2021 03:08 PM] (0) |
| Aug 24, 2021 | 29 | MODIFIED ENTRY: CORRECTED CONFIDENTIAL APPENDIX FILED by Appellant Actavis Laboratories FL, Inc. Service: 08/24/2021 by email. [795003]--[Edited 08/25/2021 by EKD - compliance review complete] [Brian Burgess] [Entered: 08/24/2021 08:19 PM] (0) |
| Aug 20, 2021 | 28 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Actavis Laboratories FL, Inc., Confidential Appendix [27], is not in compliance with the rules of this court (see attached). Compliant document is due on 08/27/2021. Service as of this date by the Clerk of Court. [794355] [EKD] [Entered: 08/20/2021 02:58 PM] (1) |
| Aug 19, 2021 | 26 | MODIFIED ENTRY: APPENDIX FILED by Appellant Actavis Laboratories FL, Inc. Service: 08/19/2021 by email. [794133] --[Edited 08/25/2021 by EKD - compliance review complete] [Brian Burgess] [Entered: 08/19/2021 04:33 PM] (643) |
| Aug 19, 2021 | 27 | CONFIDENTIAL APPENDIX FILED by Appellant Actavis Laboratories FL, Inc. Service: 08/19/2021 by email. [794139] [21-1495] This document is non-compliant. See Doc No. [28] [Brian Burgess] [Entered: 08/19/2021 04:40 PM] (0) |
| Aug 16, 2021 | 25 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Actavis Laboratories FL, Inc., Appendix [23], is not in compliance with the rules of this court (see attached). Compliant document is due on 08/23/2021. Service as of this date by the Clerk of Court. [792781] [EKD] [Entered: 08/16/2021 10:19 AM] (1) |
| Aug 13, 2021 | 24 | Certificate of Interest for Appellant Actavis Laboratories FL, Inc.. Service: 08/13/2021 by email. [792719] [21-1495] [Brian Burgess] [Entered: 08/13/2021 06:17 PM] (5) |
| Aug 13, 2021 | 23 | APPENDIX FILED by Appellant Actavis Laboratories FL, Inc. Service: 08/13/2021 by email. [792718] [21-1495] This document is non-compliant. See Doc No. [25] [Brian Burgess] [Entered: 08/13/2021 06:13 PM] (608) |
| Aug 13, 2021 | 22 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellee Tris Pharma, Inc.. Service: 08/13/2021 by email. [792710] [21-1495] [Errol Taylor] [Entered: 08/13/2021 05:28 PM] (6) |
| Aug 13, 2021 | 21 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant Actavis Laboratories FL, Inc.. Service: 08/13/2021 by email. [792664] [21-1495] [Brian Burgess] [Entered: 08/13/2021 04:03 PM] (3) |
| Aug 6, 2021 | 20 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellant Actavis Laboratories FL, Inc. Service: 08/06/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [791207] --[Edited 08/06/2021 by EKD - compliance review complete] [Brian Burgess] [Entered: 08/06/2021 03:46 PM] (37) |
| Jul 16, 2021 | 19 | MODIFIED ENTRY: RESPONSE BRIEF FILED by Appellee Tris Pharma, Inc. Service: 07/16/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [786828] --[Edited 07/16/2021 by EKD - compliance review complete] [Errol Taylor] [Entered: 07/16/2021 04:04 PM] (75) |
| Apr 23, 2021 | 18 | **TEXT ONLY** ORDER granting motion to extend time to file brief [17] filed by Appellee Tris Pharma, Inc. The response brief is due 07/16/2021. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [770728] [EKD] [Entered: 04/23/2021 08:39 AM] (0) |
| Apr 22, 2021 | 17 | MOTION of Appellee Tris Pharma, Inc. to extend the time to 07/16/2021 to file brief. Service: 04/22/2021 by email. [770601] [21-1495] [Errol Taylor] [Entered: 04/22/2021 01:28 PM] (11) |
| Apr 19, 2021 | 16 | Entry of appearance for Jordan Bock as counsel for Appellant Actavis Laboratories FL, Inc.. Service: 04/19/2021 by email. [769564] [21-1495] [Jordan Bock] [Entered: 04/19/2021 01:33 PM] (1) |
| Apr 16, 2021 | 15 | MODIFIED ENTRY: CORRECTED OPENING BRIEF FILED by Appellant Actavis Laboratories FL, Inc. Service: 04/16/2021 by email. [769295] --[Edited 04/19/2021 by EKD - compliance review complete] [Brian Burgess] [Entered: 04/16/2021 01:17 PM] (213) |
| Apr 16, 2021 | 14 | Amended Certificate of Interest for Appellant Actavis Laboratories FL, Inc.. Service: 04/16/2021 by email. [769286] [21-1495] [Brian Burgess] [Entered: 04/16/2021 01:06 PM] (4) |
| Apr 13, 2021 | 13 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Actavis Laboratories FL, Inc., Opening Brief [12], is not in compliance with the rules of this court (see attached). Compliant document is due on 04/20/2021. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [768219] [EKD] [Entered: 04/13/2021 10:11 AM] (2) |
| Apr 7, 2021 | 12 | OPENING BRIEF FILED by Appellant Actavis Laboratories FL, Inc. Service: 04/07/2021 by email. [767387] [21-1495] This document is non-compliant. See Doc No. [13] [Brian Burgess] [Entered: 04/07/2021 06:19 PM] (213) |
| Feb 16, 2021 | 11 | **TEXT ONLY** ORDER granting motion to extend time to file brief [10] filed by Appellant Actavis Laboratories FL, Inc. The opening brief is due 04/07/2021. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [756086] [EKD] [Entered: 02/16/2021 08:46 AM] (0) |
| Feb 12, 2021 | 10 | MOTION of Appellant Actavis Laboratories FL, Inc. to extend the time to 04/07/2021 to file brief. Service: 02/12/2021 by email. [755821] [21-1495] [Brian Burgess] [Entered: 02/12/2021 01:00 PM] (9) |
| Feb 2, 2021 | 9 | Corrected Entry of appearance for Brian T. Burgess; William G. James; Elizabeth J. Holland; Alexandra D. Valenti as counsel for Appellant Actavis Laboratories FL, Inc.. Service: 02/02/2021 by email. [753501] [21-1495] [Brian Burgess] [Entered: 02/02/2021 04:30 PM] (2) |
| Jan 27, 2021 | 8 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Actavis Laboratories FL, Inc., Entry of Appearance [2], is not in compliance with the rules of this court (see attached). Compliant document is due on 02/03/2021. Service as of this date by the Clerk of Court. [752058] [EKD] [Entered: 01/27/2021 12:18 PM] (1) |
| Jan 20, 2021 | 7 | Docketing Statement for the Appellee Tris Pharma, Inc.. Service: 01/20/2021 by email. [750386] [21-1495] [Lauren Drake] [Entered: 01/20/2021 04:55 PM] (3) |
| Jan 20, 2021 | 6 | Certificate of Interest for Appellee Tris Pharma, Inc.. Service: 01/20/2021 by email. [750385] [21-1495] [Lauren Drake] [Entered: 01/20/2021 04:54 PM] (3) |
| Jan 20, 2021 | 5 | Entry of appearance for Errol B. Taylor; Lauren Drake; Jordan Fernandes; Monica Arnold as counsel for Appellee Tris Pharma, Inc.. Service: 01/20/2021 by email. [750384] [21-1495] [Lauren Drake] [Entered: 01/20/2021 04:52 PM] (2) |
| Jan 20, 2021 | 4 | Docketing Statement for the Appellant Actavis Laboratories FL, Inc.. Service: 01/20/2021 by email, US mail. [750368] [21-1495] [Brian Burgess] [Entered: 01/20/2021 01:53 PM] (3) |
| Jan 20, 2021 | 3 | Certificate of Interest for Appellant Actavis Laboratories FL, Inc.. Service: 01/20/2021 by email, US mail. [750366] [21-1495] [Brian Burgess] [Entered: 01/20/2021 01:51 PM] (5) |
| Jan 20, 2021 | 2 | Entry of appearance for Brian T. Burgess; William G. James; Elizabeth J. Holland as counsel for Appellant Actavis Laboratories FL, Inc.. Service: 01/20/2021 by email, US mail. [750365] [21-1495] This document is non-compliant. See Doc No. [8] [Brian Burgess] [Entered: 01/20/2021 01:50 PM] (3) |
| Jan 6, 2021 | 1 | Appeal docketed. Received: 01/04/2021. [747273]Entry of Appearance is due on 01/20/2021. Certificate of Interest is due on 01/20/2021. Docketing Statement is due on 01/20/2021. Appellant's brief is due on 03/08/2021. [EKD] [Entered: 01/06/2021 10:37 AM] (41) |
